A number of doctor-prescribed drugs, such as copyright and Semaglutide, belong to the incretin mimetic group. Primarily , these drugs are designed to mimicking naturally occurring chemicals that regulate glucose levels and stimulate a reduction in weight . Though copyright is a commercial produc

Patients struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, copyright, is rapidly changing the landscape of weight loss. Approved by regulatory bodies for chronic weight management, Semaglutide functions as